Cargando…
Nutraceuticals in Parkinson’s Disease
Current pharmacological strategies for Parkinson’s disease (PD), the most common neurological movement disorder worldwide, are predominantly symptom relieving and are often plagued with undesirable side effects after prolonged treatment. Despite this, they remain as the mainstay treatment for PD due...
Autores principales: | Hang, Liting, Basil, Adeline Henry, Lim, Kah-Leong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983279/ https://www.ncbi.nlm.nih.gov/pubmed/27147525 http://dx.doi.org/10.1007/s12017-016-8398-6 |
Ejemplares similares
-
Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017) -
Role of the ubiquitin proteasome system in Parkinson's disease
por: Lim, Kah-Leong, et al.
Publicado: (2007) -
Nutraceuticals: An integrative approach to starve Parkinson’s disease
por: Lama, Adriano, et al.
Publicado: (2020) -
Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
por: Rakowski, Michał, et al.
Publicado: (2022) -
AF-6 Protects Against Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson’s Disease
por: Basil, Adeline H., et al.
Publicado: (2017)